First ever recorded study for CAP on Pediatric Cannula infections
🚨 Exciting News! 🚨
We are thrilled to share a groundbreaking study by Dr. Schlöglhofer, recently published in the Artificial Organs journal from Wiley. This study highlights the remarkable safety and efficacy of using SteriPlas Premium Cold Plasma for managing infections on Berlin Heart EXCOR cannulas.
🌟 This is the first publication to demonstrate the potential of CAP therapy for treating infections and inflammation in pediatric patients with paracorporeal pulsatile VADs.
Key findings show that SteriPlas treatments:
- Do not alter the surface structure of cannulas, as confirmed by SEM micrographs.
- Lead to significant improvements in DESTINE wound staging.
- Drastically reduce bacterial load and inflammatory markers.
- Achieve these results with no observed side effects.
This study marks an exciting step forward in infection management for pediatric VAD patients. To read the full publication, visit: Wiley Library.
Exhibiting at the EUMS 2024 show
Dr Schlöglhofer presents the SteriPlas at ESAO 2024
A huge congratulations to Dr Thomas Schlöglhofer for his presentation at the European Society for Artificial Organs 2024 conference.
His presentation, “Cold Atmospheric Plasma Therapy as a Novel Treatment for Berlin Heart EXCOR Pediatric Cannula Infections” features the use of our SteriPlas Premium Cold Plasma for infection management on Berlin Heart EXCOR cannulas in Pediatric patients.
We thank Dr Schlöglhofer for his work towards this study and for recommending the SteriPlas as the only Cold Plasma device for the infection management of Berlin Heart EXCOR products.
Presentation at the DFSG 2024
We enjoyed watching Jemma present on behalf of Kettering General Hospital NHS for the SteriPlas treatment of chronic diabetic foot ulcers at the Diabetic Foot Study Group (DFSG). Our Premium Cold Plasma has proven efficacy and anti-biofilm properties essential for the healing of these complex wounds.
Day 2 of the DFSG 2024
Glad to be at the Diabetic Foot Study Group (DFSG) conference catching up with existing customers and to those new who have learnt the benefits of our SteriPlas Premium Cold Plasma. We look forward to the Kettering NHS presentation later today featuring the SteriPlas efficacy for chronic Diabetic Foot Ulcers.
